Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Anilinobenzamide SCHEMBL1318994 | 0.85 | SIRT2 (0.73) | SIRT2SIRT1 | |
| SCHEMBL4158603 | 0.84 | FABP4 (0.71) | — | |
| SCHEMBL10424288 | 0.84 | SIRT2 (0.74) | SIRT2SIRT1 | |
| SCHEMBL10984674 | 0.84 | SIRT2 (0.69) | SIRT2SIRT1 | |
| SCHEMBL6620978 | 0.83 | AKR1C3 (0.57) | SIRT2 | |
| SCHEMBL8420632 | 0.83 | SIRT2 (0.74) | SIRT2SIRT1 | |
| SCHEMBL27389993 | 0.83 | SIRT2 (0.67) | SIRT2SIRT1 | |
| SCHEMBL5992131 | 0.83 | SIRT2 (0.67) | SIRT2SIRT1 | |
| SCHEMBL30982117 | 0.83 | AKR1C3 (0.57) | SIRT2 | |
| SCHEMBL15688476 | 0.83 | SIRT2 (0.71) | SIRT2SIRT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1602648-B1 | Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same | IDEMITSU KOSAN CO (JP) | 2013-04-17 | — | — | EP | disclosed |
| US-7851071-B2 | 2-[4-(10-naphthalene-2-yl-anthracene-9-yl)-phenyl]-1-phenyl-1H-benzimidazole; elevation of luminance and of efficiency in light emission even under low driving voltage | IDEMITSU KOSAN CO., LTD. (JP) | 2010-12-14 | — | — | US | disclosed |
| US-20100193773-A1 | Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same | IDEMITSU KOSAN CO., LTD, (JP) | 2010-08-05 | — | — | US | disclosed |
| EP-2174933-A2 | Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same | Idemitsu Kosan Co., Ltd. (JP) | 2010-04-14 | — | — | EP | disclosed |
| EP-2174932-A2 | Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same | Idemitsu Kosan Co., Ltd. (JP) | 2010-04-14 | — | — | EP | disclosed |
| US-20060147747-A1 | 2-[4-(10-naphthalene-2-yl-anthracene-9-yl)-phenyl]-1-phenyl-1H-benzimidazole; elevation of luminance and of efficiency in light emission even under low driving voltage | IDEMITSU KOSAN CO., LTD. (JP) | 2006-07-06 | — | — | US | disclosed |
| EP-1602648-A1 | NITROGEN-CONTAINING HETEROCYCLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2005-12-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100193773-A1 | Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same | NSD1, EED, ERG | SIRT2 1049/4885SIRT1 1186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.